Hongling Wang

2.3k citations
58 papers · 1.6k indexed · 1 hit paper · h-index 20
Topics
Cancer-related molecular mechanisms research (6 papers)MicroRNA in disease regulation (5 papers)Cancer, Hypoxia, and Metabolism (5 papers)

In The Last Decade

Hongling Wang

52 papers receiving 1.5k citations

Hit Papers

Clinical Characteristics of Refractory Coronavirus Diseas...20202026202220242020200400600

Peers

Hongling Wang
Comparison fields: 5 of 126
  • Infectious Diseases 606
  • Molecular Biology 482
  • Neurology 331
  • Cancer Research 288
  • Oncology 271
Replace Baoguang Hu with:
Baoguang Hu China
Furong Zeng China
Yuehong Chen China
Yigang Zeng China
Jun Lin China
Jiong Yu China
Yan Xiong China
Qin‐Yan Gao China
Jun Ye China
Jarom Heijmans Netherlands
Hongling Wang relative to Baoguang Hu China Baoguang Hu's profile →
Citations per field
00.5×1.5×2.5×
Baoguang Hu · 1×
Citations per year

Countries citing papers authored by Hongling Wang

Since Specialization
Citations

This map shows the geographic impact of Hongling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongling Wang more than expected).

Fields of papers citing papers by Hongling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongling Wang. The network helps show where Hongling Wang may publish in the future.

Co-authorship network of co-authors of Hongling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongling Wang. A scholar is included among the top collaborators of Hongling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongling Wang. Hongling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 5
5 17
6 66
7 6
8 6
9 15
10 21
11 17
12 48
13 24
14 33
15 1
16 62
17 30
18 22
19 1
20 42

About Hongling Wang

Hongling Wang is a scholar working on Cancer Research, Gastroenterology and Hepatology, having authored 58 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Infectious Diseases (606 citations), Neurology (331 citations) and Cancer Research (288 citations). Hongling Wang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Qiu Zhao, Fan Wang, Yongxi Zhang, Pingzheng Mo, Yuanyuan Xing, Mingqi Luo, Liping Deng, Ruiying Zheng, Qian Cao and Yong Xiong. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026